InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Ignelzi Troy A., Chief Financial Officer. Insider active across 2 companies, notably Karuna Therapeutics, Inc.. In total, 18 filings have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €660k. History available since 10 May 2021. The latest transaction was filed on 12 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Ignelzi Troy A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
9,900 shares@ US$10.10100.0% of flowCommon StockSEC:0000950170-25-038878:0
Canonical exit: 10 Jun 2025 (T+90)
1,500 shares@ US$9.200.7% of flowCommon StockSEC:0000950170-23-044413:0
9,000 shares@ US$9.204.3% of flowCommon StockSEC:0000950170-23-024286:0
6,000 shares@ US$9.202.9% of flowCommon StockSEC:0001593968-23-000345:0
8,650 shares0Common StockSEC:0001593968-23-000304:0
817 shares@ US$9.200.4% of flowCommon StockSEC:0001593968-23-000170:0
10,869 shares@ US$9.205.2% of flowCommon StockSEC:0001593968-22-001741:0
16,500 shares@ US$9.208.2% of flowCommon StockSEC:0001593968-22-001609:0
2,459 shares@ US$227.0531.6% of flowCommon StockSEC:0001593968-22-001490:0
16,500 shares@ US$9.208.3% of flowCommon StockSEC:0001593968-22-001335:0
3,500 shares@ US$9.204.3% of flowCommon StockSEC:0001593968-22-000886:0
1,500 shares@ US$9.201.8% of flowCommon StockSEC:0001593968-22-000496:0
5,869 shares@ US$9.203.3% of flowCommon StockSEC:0001593968-21-002566:0
13,500 shares@ US$9.207.3% of flowCommon StockSEC:0001593968-21-002380:0
7,000 shares@ US$9.203.7% of flowCommon StockSEC:0001593968-21-002107:0
5,000 shares@ US$9.202.7% of flowCommon StockSEC:0001593968-21-002003:0
2,248 shares@ US$9.201.2% of flowCommon StockSEC:0001593968-21-001633:0
7,000 shares@ US$9.203.6% of flowCommon StockSEC:0001593968-21-001292:0
18 of 18 declarations
About Ignelzi Troy A.
Ignelzi Troy A. is Chief Financial Officer at Karuna Therapeutics, Inc. and Rapport Therapeutics, Inc. He has 18 filings in total, and across the 18 sampled filings the transactions run from 2021-05-12 to 2025-03-13, with EUR 91,615 of buys and EUR 567,997 of sells; the modal transaction nature is option exercise.
